The global struggle against the "superbug" crisis has reached a critical turning point, with the market for specialized treatments now valued at approximately $12.1 billion. For years, the rapid evolution of bacterial resistance threatened to render modern surgery and cancer care impossible, but 2026 has seen a resurgence in the antimicrobial pipeline. This year, the industry is witnessing the...
Turkish 
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt